The stock jump comes just two days after the Sunrise, Fla.-based anesthesiology ownership company announced the acquisition of two medical practices, an anesthesia and a pediatric surgery practice.
Just six months ago, MEDNAX stock hit a 52-week low of $59.24.
More Articles on Anesthesia:
FDA Recalls Bunnell Ventilator Patient Circuits
Tennessee Anesthesia, Texas Pediatric Surgery Practices Acquired by MEDNAX
Children’s Pain Scores Tied to Ethnicities
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
